Plexus (NASDAQ:PLXS) Receives Buy Rating from Benchmark

Benchmark reissued their buy rating on shares of Plexus (NASDAQ:PLXS) in a research report released on Monday morning,Benzinga reports. The firm currently has a $220.00 price objective on the technology company’s stock.

Other research analysts have also recently issued research reports about the stock. Needham & Company LLC upped their target price on shares of Plexus from $165.00 to $206.00 and gave the company a “buy” rating in a report on Friday, January 30th. Weiss Ratings upgraded shares of Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, March 6th. Wall Street Zen downgraded shares of Plexus from a “buy” rating to a “hold” rating in a research note on Sunday, March 8th. Zacks Research raised Plexus from a “hold” rating to a “strong-buy” rating in a report on Friday, February 6th. Finally, Williams Trading set a $195.00 price objective on Plexus in a report on Wednesday, January 28th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $194.20.

Plexus Price Performance

Shares of NASDAQ PLXS opened at $194.42 on Monday. The stock’s 50-day simple moving average is $189.08 and its 200-day simple moving average is $160.58. The firm has a market capitalization of $5.21 billion, a PE ratio of 30.24 and a beta of 0.81. Plexus has a fifty-two week low of $103.43 and a fifty-two week high of $211.84. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.75 and a current ratio of 1.59.

Plexus (NASDAQ:PLXS) last announced its quarterly earnings results on Wednesday, January 28th. The technology company reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.77 by $0.01. The firm had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.07 billion. Plexus had a return on equity of 12.39% and a net margin of 4.28%.The firm’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the company posted $1.73 earnings per share. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. As a group, equities research analysts forecast that Plexus will post 5.9 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Frank Zycinski sold 1,399 shares of the firm’s stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $205.99, for a total value of $288,180.01. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Patrick John Jermain sold 2,321 shares of the firm’s stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $201.12, for a total value of $466,799.52. Following the completion of the sale, the chief financial officer directly owned 14,561 shares of the company’s stock, valued at $2,928,508.32. This represents a 13.75% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 47,995 shares of company stock worth $9,718,476. 1.78% of the stock is currently owned by insiders.

Institutional Trading of Plexus

A number of institutional investors have recently bought and sold shares of the company. AQR Capital Management LLC increased its position in shares of Plexus by 103.1% in the first quarter. AQR Capital Management LLC now owns 8,384 shares of the technology company’s stock valued at $1,074,000 after buying an additional 4,255 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Plexus by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,971 shares of the technology company’s stock valued at $2,046,000 after acquiring an additional 705 shares in the last quarter. United Services Automobile Association acquired a new position in Plexus during the first quarter worth about $218,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Plexus by 12.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 79,584 shares of the technology company’s stock valued at $10,197,000 after purchasing an additional 9,078 shares in the last quarter. Finally, Bank of Montreal Can lifted its holdings in shares of Plexus by 4.0% in the second quarter. Bank of Montreal Can now owns 4,488 shares of the technology company’s stock valued at $607,000 after purchasing an additional 172 shares in the last quarter. 94.45% of the stock is currently owned by hedge funds and other institutional investors.

Plexus Company Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.